Ancora Advisors LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 8 filers reported holding PDL BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2023$04,9480.0%0.00%
Q2 2023$04,9480.0%0.00%
Q1 2023$04,9480.0%0.00%
Q4 2022$04,9480.0%0.00%
Q3 2022$04,9480.0%0.00%
Q2 2022$04,9480.0%0.00%
Q1 2022$04,9480.0%0.00%
Q4 2021$04,9480.0%0.00%
Q3 2021$04,9480.0%0.00%
Q2 2021$04,9480.0%0.00%
Q1 2021$0
-100.0%
4,9480.0%0.00%
Q4 2020$12,000
-99.2%
4,948
-98.9%
0.00%
-100.0%
Q3 2020$1,455,000
-70.5%
461,723
-72.7%
0.06%
-71.8%
Q2 2020$4,927,000
-1.7%
1,693,216
-4.7%
0.21%
-11.2%
Q1 2020$5,011,000
-7.8%
1,776,784
+6.1%
0.23%
+14.9%
Q4 2019$5,435,000
+594.1%
1,674,961
+362.0%
0.20%
+494.1%
Q3 2019$783,000
-31.1%
362,524
+0.2%
0.03%
-33.3%
Q2 2019$1,136,000
-29.0%
361,878
-15.9%
0.05%
-30.1%
Q1 2019$1,601,000
+16.9%
430,304
-8.9%
0.07%
+10.6%
Q4 2018$1,370,000
+91.1%
472,507
+73.3%
0.07%
+135.7%
Q3 2018$717,000272,7070.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders